Patents by Inventor Hans-Jochem Kolb

Hans-Jochem Kolb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6551592
    Abstract: According to the invention, a method is provided wherein intact bispecific or trispecific antibodies which at the same time bind to the T cell receptor complex of a T cell, to tumor-associated antigens on a tumor cell, and, via the Fc portion of the bispecific antibody, to Fc receptor-positive cells are used for the induction of an anti-tumour immunity in humans and animals.
    Type: Grant
    Filed: September 3, 1997
    Date of Patent: April 22, 2003
    Assignee: GSF Forschungszentrum fur Umwelt und Gesundheit GmbH
    Inventors: Horst Lindhofer, Hans-Jochem Kolb, Stefan Thierfelder
  • Publication number: 20020051780
    Abstract: According to the invention, a method is provided wherein intact bispecific or trispecific antibodies which at the same time bind to the T cell receptor complex of a T cell, to tumour-associated antigens on a tumour cell, and, via the Fc portion of the bispecific antibody, to Fc receptor-positive cells are used for the induction of an anti-tumour immunity in humans and animals.
    Type: Application
    Filed: September 3, 1997
    Publication date: May 2, 2002
    Inventors: HORST LINDHOFER, HANS-JOCHEM KOLB, STEFAN THIERFELDER
  • Patent number: 6210668
    Abstract: The present invention discloses a procedure for the destruction of contaminating tumor cells in stem cell transplants ex vivo using intact bispecific antibodies.
    Type: Grant
    Filed: October 21, 1999
    Date of Patent: April 3, 2001
    Assignee: GSF Forschungszentrum fur Umwelt und Gesundheit GmbH
    Inventors: Horst Lindhofer, Helge Menzel, Hans-Jochem Kolb, Stefan Thierfelder
  • Patent number: 5985276
    Abstract: The present invention discloses a procedure for the destruction of contaminating tumor cells in stem cell transplants ex vivo using intact bispecific antibodies.
    Type: Grant
    Filed: September 3, 1997
    Date of Patent: November 16, 1999
    Assignee: GSF Forschungszentrum fur Umwelt und Gesundheit GmbH
    Inventors: Horst Lindhofer, Helge Menzel, Hans-Jochem Kolb, Stefan Thierfelder